| 发明名称 |
The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc). |
| 摘要 |
The use of sGC stimulators, sGC activators alone, or in combination with PDE5 inhibitors for the prevention and treatment of fibrotic diseases, such as systemic sclerosis, scleroderma, and the concomitant fibrosis of internal organs. |
| 申请公布号 |
AU2011257336(B2) |
申请公布日期 |
2015.11.19 |
| 申请号 |
AU20110257336 |
申请日期 |
2011.05.24 |
| 申请人 |
ADVERIO PHARMA GMBH |
发明人 |
HIRTH-DIETRICH, CLAUDIA;SANDNER, PETER;STASCH, JOHANNES-PETER;KNORR, ANDREAS;VON DEGENFELD, GEORGES;HAHN, MICHAEL;FOLLMANN, MARKUS |
| 分类号 |
C07D471/04;A61K31/437;A61P9/00;A61P15/00 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
